SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000819050-22-000014
Filing Date
2022-03-15
Accepted
2022-03-15 07:33:10
Documents
15
Period of Report
2022-03-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bbi-20220315.htm   iXBRL 8-K 32565
2 EX-99.1 a20211231ex991pressrelease.htm EX-99.1 81948
6 bbi-20220315_g1.jpg GRAPHIC 6568
7 logoa04a.jpg GRAPHIC 4821
  Complete submission text file 0000819050-22-000014.txt   289903

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bbi-20220315.xsd EX-101.SCH 1909
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bbi-20220315_lab.xml EX-101.LAB 25154
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bbi-20220315_pre.xml EX-101.PRE 13055
9 EXTRACTED XBRL INSTANCE DOCUMENT bbi-20220315_htm.xml XML 11253
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Brickell Biotech, Inc. (Filer) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21088 | Film No.: 22739129
SIC: 2836 Biological Products, (No Diagnostic Substances)